Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.
| Revenue (TTM) | $1.83M |
| Gross Profit (TTM) | 548,020 |
| EBITDA | $-28.34M |
| Operating Margin | -3249.00% |
| Return on Equity | -199.10% |
| Return on Assets | -98.00% |
| Revenue/Share (TTM) | $1.16 |
| Book Value | $1.39 |
| Price-to-Book | 0.22 |
| Price-to-Sales (TTM) | 1.49 |
| EV/Revenue | 0.145 |
| EV/EBITDA | 3.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -35.00% |
| Shares Outstanding | $7.20M |
| Float | $5.35M |
| % Insiders | 24.10% |
| % Institutions | 4.19% |
Volatility is currently contracting